tm logo
VYEPTI 3V
SEARCHED

on 26 Mar 2024

Last Applicant/ Owned by

H. LUNDBECK A/S

Ottiliavej 92500 Valby,

DK

Serial Number

2182887 filed on 02th May 2022

Correspondent Address

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

VYEPTI 3V

Trademark usage description

pharmaceutical preparations used for the prevention, management and treatment of headaches, migraines, pain, immune and inflammatory disorders and dis Read More

Classification Information


Class [005]
Pharmaceutical preparations used for the prevention, management and treatment of headaches, migraines, pain, immune and inflammatory disorders and diseases namely pharmaceutical preparations for regulating the immune system, pharmaceutical preparations for the treatment of autoimmune diseases, pharmaceutical preparations for the treatment of immunologic diseases namely autoimmune diseases, immunologic deficiency syndromes, anti-inflammatories, pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders, and neurological disorders and conditions namely pharmaceutical preparations for the treatment of neurological diseases namely, Alzheimer's, Huntington's disease, cerebral palsy, pharmaceutical preparations for the treatment of neurological disorders namely brain injury, spinal cord injury, seizure disorders.


Classification kind code

11

Class [010]
Surgical and medical apparatus and instruments, namely, knives for surgical use, lasers for surgical and medical use, medical and surgical catheters, medical and surgical laparoscopes, surgical clamps, surgical drills, surgical instruments, dispensers, namely, aerosol dispensers for medical purposes, needles, syringes; medical devices, namely, syringes and pumps for administering drugs, syringes and needles for injections and for medical purposes; apparatus and instruments, namely, test kits for testing neurological diseases, namely, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency for diagnostic purposes; integrated medical systems containing medical apparatus, namely drainage tubes, electrodes, incubators, injection needles, irrigators, guide wires, respirators, dispensers, namely, aerosol dispensers for medical purposes, needles, syringes, and software for information storage, information management, and for accessing information in the fields of neurology, neurological diseases and disorders, and brain diseases and disorders for use in Web-based physical and psychological and neurological examination and assessment of patients and clients at a distance and at a clinic; medical instruments, namely, drainage tubes, electrodes, incubators, injection needles, irrigators, guide wires, respirators, dispensers, namely, aerosol dispensers for medical purposes for information, guidance, management and control of medicines.


Classification kind code

11

Mark Details


Serial Number

2182887

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 26th Mar 2024
Search Recorded
Submitted for opposition 20
on 26th Mar 2024
Examiner's First Report
Submitted for opposition 67
on 07th Oct 2022
Agent Name Changed
Submitted for opposition 287
on 19th Jul 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 02th May 2022
Filed
Submitted for opposition 1
on 02th May 2022
Created
Submitted for opposition 31
on 02th May 2022
Formalized